Agio Pharmaceuticals Limited — Dexamethasone Exporter Profile
Indian Pharmaceutical Exporter · #13 for Dexamethasone · $1.9M export value · DGFT Verified
Agio Pharmaceuticals Limited is the #13 Indian exporter of Dexamethasone with $1.9M in export value and 84 verified shipments. Agio Pharmaceuticals Limited holds a 1.1% market share in Dexamethasone exports across 7 countries. The company exports 15 pharmaceutical products worth $11.9M across 8 therapeutic categories.
Agio Pharmaceuticals Limited — Dexamethasone Export Profile: Buyers & Destinations
Where Does Agio Pharmaceuticals Limited Export Dexamethasone?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UZBEKISTAN | $789.9K | 31 | 44.6% |
| KAZAKISTAN | $410.3K | 19 | 23.2% |
| KAZAKHSTAN | $241.8K | 9 | 13.7% |
| MOLDOVA,REPUBLIC OF | $111.6K | 10 | 6.3% |
| GEORGIA | $80.5K | 6 | 4.5% |
| KYRGHYSTAN | $73.9K | 5 | 4.2% |
| MOLDOVAREPUBLIC OF | $36.2K | 3 | 2.0% |
| TURKMENISTAN | $27.0K | 1 | 1.5% |
Agio Pharmaceuticals Limited exports Dexamethasone to 8 countries. The largest destination is UZBEKISTAN accounting for 44.6% of Agio Pharmaceuticals Limited's Dexamethasone shipments, followed by KAZAKISTAN (23.2%) and KAZAKHSTAN (13.7%). These destinations reflect Agio Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Dexamethasone from Agio Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AGIO HEALTHCARE INTERNATIONAL LLC | UZBEKISTAN | $496.4K | 23 |
| LLP AGIO PHARMACEUTICALS LIMITED | KAZAKISTAN | $358.6K | 11 |
| AMRITA PHARMA LLC | UZBEKISTAN | $258.3K | 7 |
| LLC AK NEIT | KAZAKISTAN | $239.7K | 10 |
| ESCULAP FARM | MOLDOVA,REPUBLIC OF | $147.8K | 13 |
| AVERSI PHARMA LLC | GEORGIA | $80.5K | 6 |
| OSOO ELYAI | KYRGHYSTAN | $62.9K | 4 |
| AMRITA PHARMA LLC, | UZBEKISTAN | $35.3K | 1 |
| SAGLYK E S | TURKMENISTAN | $27.0K | 1 |
| LLC AK NEIT REPUBLIC OF KAZAKHSTAN CITY SHYMKENT TURAN | KAZAKHSTAN | $25.7K | 1 |
Agio Pharmaceuticals Limited supplies Dexamethasone to 15 buyers globally. The largest buyer is AGIO HEALTHCARE INTERNATIONAL LLC (UZBEKISTAN), followed by LLP AGIO PHARMACEUTICALS LIMITED (KAZAKISTAN) and AMRITA PHARMA LLC (UZBEKISTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Dexamethasone Export Value and How Much Does Agio Pharmaceuticals Limited Contribute?
India exported $32.1M worth of Dexamethasone through 8,777 shipments from 808 suppliers to 176 countries, serving 2,257 buyers globally. Agio Pharmaceuticals Limited contributes $1.9M to this total, accounting for 1.1% of India's Dexamethasone exports. Agio Pharmaceuticals Limited ships Dexamethasone to 8 countries through 15 buyers.
What Is the Average Shipment Value for Agio Pharmaceuticals Limited's Dexamethasone Exports?
Agio Pharmaceuticals Limited's average Dexamethasone shipment value is $22.8K per consignment, based on 84 shipments totaling $1.9M. The largest destination is UZBEKISTAN (44.6% of Agio Pharmaceuticals Limited's Dexamethasone exports).
How Does Agio Pharmaceuticals Limited Compare to Other Indian Dexamethasone Exporters?
Agio Pharmaceuticals Limited ranks #13 among 808 Indian Dexamethasone exporters with a 1.1% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($6.1M), SENTISS PHARMA PRIVATE LIMITED ($4.5M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($3.3M). Agio Pharmaceuticals Limited processed 84 shipments to 7 destination countries.
What Dexamethasone Formulations Does Agio Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| DEXAMETHASONE - AGIO SOLUTION FOR INJECTION 4MG/ML (DEXAMETHASONE SODIUM PHOSPHATE INJECTION BP) | $657.9K | 22 |
| DEXAMETHASONE - AGIO SOLUTION FOR INJECT | $330.4K | 20 |
| DEXAMETHASONE AGIO SOLUTION FOR INJECTIO | $135.0K | 3 |
| DEXAMETHASONE - AGIO SOLUTION FORINJECTION 4MG/ML (DEXAMETHASONE SODIUMPHOSPHATE INJECTION BP)NOS | $85.0K | 6 |
| DDEXAMETHASONE - AGIO SOLUTION FOR INJECTION 4MG/ML (DEXAMETHASONE SODIUM PHOSPHATE INJECTION BP)NOS | $58.3K | 3 |
| DEXAMETHASONE - AGIO SOLUTION FOR INJECTION 4MG/ML | $50.0K | 1 |
| DEXAMETHASONE-AGIO SOLUTION FOR INJECTION 4MG/ML (DEXAMETHASONE SODIUM PHOSPHATEINJECTION BP) | $47.2K | 1 |
| DEXAMETHASONE-AGIO SOLUTION FOR INJ.4MG/MLDEXAMETHASONE SODIUM PHOSPHATE INJ. BPBNO.I23061 TO I23065 MD.10/23 ED.09/25 | $40.6K | 1 |
| DEXAMETHASONE - AGIO SOLUTION FOR INJ. | $37.9K | 2 |
| DEXAMETHASONE INJECTION 4MG/ML (DEXAMETHASONE SODIUM PHOSPHATE INJECTION BP)NOS | $35.4K | 2 |
Agio Pharmaceuticals Limited exports 29 distinct Dexamethasone formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DEXAMETHASONE - AGIO SOLUTION FOR INJECTION 4MG/ML (DEXAMETH with 22 shipments worth $657.9K.
How Does Agio Pharmaceuticals Limited Compare to Nearest Dexamethasone Exporters?
Exporters ranked immediately above and below #13 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | DR.REDDY'S LABORATORIES LTD | $2.3M | 46 | 1 | $50.0K |
| 10 | SOMERSET THERAPEUTICS LIMITED | $2.2M | 44 | 1 | $50.0K |
| 13 | AGIO PHARMACEUTICALS LIMITED ★ | $1.9M | 84 | 7 | $22.8K |
| 14 | SOMERSET THERAPEUTICS PRIVATE LIMITED | $1.3M | 25 | 1 | $50.0K |
| 2 | DR REDDYS LABORATORIES LIMITED | $1.1M | 22 | 1 | $50.0K |
Agio Pharmaceuticals Limited ranks #13 among 808 Indian Dexamethasone exporters. Average shipment value of $22.8K compared to the market average of $39.8K. The closest competitors by value are DR.REDDY'S LABORATORIES LTD and SOMERSET THERAPEUTICS LIMITED.
Which Indian Ports Ship Dexamethasone Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,214 | 13.8% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,121 | 12.8% |
| NHAVA SHEVA SEA (INNSA1) | 748 | 8.5% |
| DELHI AIR CARGO ACC (INDEL4) | 509 | 5.8% |
| DELHI AIR | 476 | 5.4% |
| JNPT/ NHAVA SHEVA SEA | 472 | 5.4% |
| Bombay Air | 327 | 3.7% |
| JNPT | 320 | 3.6% |
Geopolitical & Trade Policy Impact on Agio Pharmaceuticals Limited's Dexamethasone Exports
Recent geopolitical developments have introduced complexities into the pharmaceutical export landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight charges and potential losses for Indian exporters. According to Pharmaceutical Commerce, maritime carriers' booking suspensions and diversions around the Cape of Good Hope are elongating lead times and pressurizing Suez-linked lanes, disproportionately impacting time-sensitive pharmaceutical replenishment cycles. This situation poses challenges for Agio Pharmaceuticals, particularly in maintaining timely deliveries to key markets.
In the United States, recent tariff implementations have affected a significant portion of Indian exports. The Federation of Indian Export Organisations highlighted that the latest U.S. tariffs impact nearly 55% of India's outbound shipments to America, placing Indian exporters at a competitive disadvantage. For Agio, which relies on the U.S. market, these tariffs could necessitate strategic adjustments to pricing and supply chain logistics.
The European Union's stringent regulatory changes, including the Falsified Medicines Directive, demand enhanced compliance measures from exporters. Agio's ability to adapt to these evolving standards will be crucial in sustaining its market presence in the EU.
Agio Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the U.S. FDA increasing inspections of manufacturing facilities. India, hosting over 600 US FDA-approved sites, faces challenges in maintaining compliance. The US FDA conducted more than 200 inspections in 2023, with plans to increase this number in 2024. For Agio Pharmaceuticals, ensuring adherence to Good Manufacturing Practices (GMP) and other quality standards is imperative to avoid potential export bans or reputational damage.
Additionally, the prevalence of counterfeit drugs has raised concerns about India's reputation as a reliable supplier. Agio must implement robust quality control systems and transparent governance to navigate this landscape effectively.
About Agio Pharmaceuticals Limited
Agio Pharmaceuticals Limited exports 15 products worth $11.9M. Beyond Dexamethasone, top products include Phenylephrine, Clotrimazole, Prednisolone, Salbutamol, Bromhexine. View the complete Agio Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Dexamethasone — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Dexamethasone shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Agio Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 84 individual customs records matching Agio Pharmaceuticals Limited exporting Dexamethasone, covering 29 formulations to 8 countries via 15 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 176+ countries, 2,257+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Dexamethasone Export Data from Agio Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Agio Pharmaceuticals Limited's Dexamethasone exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Agio Pharmaceuticals Limited
Full Company Profile →
15 products · $11.9M total trade · 8 categories
Dexamethasone Stats
Company Overview
Top Products by Agio Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Agio Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Dexamethasone. For current shipment-level data, contact TransData Nexus.